{
    "clinical_study": {
        "@rank": "43394", 
        "acronym": "BPD", 
        "arm_group": [
            {
                "arm_group_label": "Montelukast", 
                "arm_group_type": "Experimental", 
                "description": "montelukast sodium\ndosage\n< 1000g : 0.5 mg/D QD\n1000g~1500g : 1.0 mg/D QD\n1500g~2000g : 1.5 mg/D QD\n> 2000g : 2mg/D QD\nmedication period : to discharge or GA 36wks"
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "No Intervention", 
                "description": "Standard treatment of BPD and preterm infants"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is multicentered, prospective, randomized, opened, parallel, intervention study.\n\n      The aim of this study is to evaluate the efficacy and safety of Montelukast sodium in the\n      prevention of bronchopulmonary dysplasia (BPD) in preterm infant, below 32weeks gestational\n      age.\n\n      The investigators evaluate the first effectiveness through the morbidity and mortality of\n      bronchopulmonary dysplasia. And then, the investigators evaluate the second effectiveness\n      through the oxygen index, the usage of mechanical ventilator about taking medicine after 2\n      Weeks, Oxygen Utilization After 4 Weeks, Proinflammatory Cytokine through the bronchial\n      lavage fluid."
        }, 
        "brief_title": "The Efficacy and Safety of Montelukast Sodium in the Prevention of Bronchopulmonary Dysplasia", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Premature Birth", 
            "Infant, Very Low Birth Weight", 
            "Bronchopulmonary Dysplasia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Birth Weight", 
                "Bronchopulmonary Dysplasia", 
                "Premature Birth"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Preterm infants born at less than 32 weeks\n\n          -  Birth 14 days after, oxygen or artificial ventilation who are using patient\n\n          -  more than 20cal/kg/d by enteral feeding\n\n          -  written consent of the parents\n\n        Exclusion Criteria:\n\n          -  congenital anomaly\n\n          -  cardiovascular collapse\n\n          -  investigator's opinion"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "10 Weeks", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "72", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 26, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01717625", 
            "org_study_id": "AJIRB-MED-CT2-11-242"
        }, 
        "intervention": {
            "arm_group_label": "Montelukast", 
            "description": "a leukotriene D4 receptor antagonist; sodium salt is the active compound; structure in first source", 
            "intervention_name": "Montelukast", 
            "intervention_type": "Drug", 
            "other_name": "Singulair"
        }, 
        "intervention_browse": {
            "mesh_term": "Montelukast"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "montelukast", 
            "BPD", 
            "singulair", 
            "prematurity"
        ], 
        "lastchanged_date": "July 1, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Suwon", 
                    "country": "Korea, Republic of", 
                    "state": "Woncheon-dong, Yeongtong-gu,", 
                    "zip": "443-721"
                }, 
                "name": "Ajou university medical center"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Efficacy and Safety of Montelukast Sodium in the Prevention of Bronchopulmonary Dysplasia", 
        "overall_official": {
            "affiliation": "Ajou University", 
            "last_name": "Moonsung Park, professor", 
            "role": "Study Chair"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": [
                "Korea: Food and Drug Administration", 
                "Korea: Institutional Review Board"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "At corrected gestational age 36 weeks, to compare the incidence of moderate to severe BPD or mortality", 
            "measure": "Incidence of moderate to severe BPD or mortality", 
            "safety_issue": "No", 
            "time_frame": "corrected gestational age"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01717625"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ajou University School of Medicine", 
            "investigator_full_name": "Lee Janghoon", 
            "investigator_title": "Assistant professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Oxygen Index. Use of mechanical ventilation, oxygen, systemic steroid. Weight gain, adverse event", 
            "safety_issue": "Yes", 
            "time_frame": "1, 2, 4 weeks since starting study"
        }, 
        "source": "Ajou University School of Medicine", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Severance Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Seoul National University Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Gangnam Severance Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Korea University", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Ajou University School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}